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Introduction: Pain is a major global health issue, where its pharmacotherapy prompts 
unwanted side effects; hence, the development of effective alternative compounds from 
natural derivatives with lesser side effects is clinically needed. Chalcone; the precursors of 
flavonoid, and its derivatives have been widely investigated due to its pharmacological 
properties. Objective: This study addressed the therapeutic effect of 3- (2,5-
dimethoxyphenyl)-1-(5-methyl furan-2-yl) prop-2-en-1-one (DMPF-1); synthetic chalcone 
derivative, on antinociceptive activity in vivoMaterials and Methods: The antinociceptive 
profile was evaluated using acetic-acid-induced abdominal writhing, hot plate, and formalin-
induced paw licking test. Capsaicin, phorbol 12-myristate 12 acetate (PMA), and glutamate-
induced paw licking test were carried out to evaluate their potential effects toward different 
targets. Results: It was shown that the doses of 0.1, 0.5, 1, and 5 mg/kg of DMPF-1 given via 
intraperitoneal injection showed significant reduction in writhing responses and increased 
the latency time in hot-plate test where reduced time spent on licking the injected paw in 
formalin and dose contingency inhibition was observed. The similar results were observed in 
capsaicin, PMA, and glutamate-induced paw licking test. In addition, the challenge with 
nonselective opioid receptor antagonist (naloxone) aimed to evaluate the involvement of the 
opioidergic system, which showed no reversion in analgesic profile in formalin and hot-plate 
test. Conclusion: Collectively, this study showed that DMPF-1 markedly inhibits both 
peripheral and central nociception through the mechanism involving an interaction with 
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